The funds’ strategy is to invest in EIS qualifying companies involved in the development, commercialisation and sale of innovative technologies or use them to gain a competitive advantage.
Strategy: Exposure to a portfolio of early startup or early stage technology companies.
Portfolio Risk: Early stage companies carry significant risk, though Symvan have had no
failures to date.
Team: Symvan bring a broad range of capital markets experience and a focus on a company’s funding needs throughout its investment period.
Depth of Staff: The Symvan team is very small, though has very experienced advisors and only a few companies to manage.